nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—Hyperuricaemia—Tretinoin—peripheral nervous system neoplasm	0.0151	0.0158	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Isotretinoin—peripheral nervous system neoplasm	0.0151	0.0158	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Melphalan—peripheral nervous system neoplasm	0.0149	0.0156	CcSEcCtD
Hydroflumethiazide—Vasculitis—Tretinoin—peripheral nervous system neoplasm	0.0144	0.015	CcSEcCtD
Hydroflumethiazide—Vasculitis—Isotretinoin—peripheral nervous system neoplasm	0.0144	0.015	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Tretinoin—peripheral nervous system neoplasm	0.0143	0.0149	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Isotretinoin—peripheral nervous system neoplasm	0.0143	0.0149	CcSEcCtD
Hydroflumethiazide—Vasculitis—Melphalan—peripheral nervous system neoplasm	0.0142	0.0148	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Melphalan—peripheral nervous system neoplasm	0.0141	0.0147	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Isotretinoin—peripheral nervous system neoplasm	0.0116	0.0121	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Tretinoin—peripheral nervous system neoplasm	0.0116	0.0121	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Alitretinoin—peripheral nervous system neoplasm	0.0115	0.0119	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Vincristine—peripheral nervous system neoplasm	0.011	0.0115	CcSEcCtD
Hydroflumethiazide—Vasculitis—Alitretinoin—peripheral nervous system neoplasm	0.0109	0.0114	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Alitretinoin—peripheral nervous system neoplasm	0.0108	0.0113	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Dactinomycin—peripheral nervous system neoplasm	0.0108	0.0112	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Vincristine—peripheral nervous system neoplasm	0.0104	0.0109	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Cisplatin—peripheral nervous system neoplasm	0.00976	0.0102	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Topotecan—peripheral nervous system neoplasm	0.00924	0.00963	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Cisplatin—peripheral nervous system neoplasm	0.00922	0.00961	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Etoposide—peripheral nervous system neoplasm	0.00894	0.00932	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00878	0.00916	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Isotretinoin—peripheral nervous system neoplasm	0.00862	0.00899	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Tretinoin—peripheral nervous system neoplasm	0.00862	0.00899	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Etoposide—peripheral nervous system neoplasm	0.00845	0.00881	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Isotretinoin—peripheral nervous system neoplasm	0.00803	0.00837	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Tretinoin—peripheral nervous system neoplasm	0.00803	0.00837	CcSEcCtD
Hydroflumethiazide—Jaundice—Melphalan—peripheral nervous system neoplasm	0.00755	0.00787	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00732	0.00763	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00732	0.00763	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Alitretinoin—peripheral nervous system neoplasm	0.00654	0.00681	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.00608	0.00634	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Cisplatin—peripheral nervous system neoplasm	0.006	0.00626	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00598	0.00624	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.00594	0.00619	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Cisplatin—peripheral nervous system neoplasm	0.00592	0.00617	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.00586	0.00611	CcSEcCtD
Hydroflumethiazide—Glycosuria—Epirubicin—peripheral nervous system neoplasm	0.00574	0.00598	CcSEcCtD
Hydroflumethiazide—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.00563	0.00587	CcSEcCtD
Hydroflumethiazide—Agitation—Tretinoin—peripheral nervous system neoplasm	0.00563	0.00587	CcSEcCtD
Hydroflumethiazide—SLC12A1—ganglion—peripheral nervous system neoplasm	0.00561	0.137	CbGeAlD
Hydroflumethiazide—Pancreatitis—Cisplatin—peripheral nervous system neoplasm	0.00557	0.00581	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00555	0.00578	CcSEcCtD
Hydroflumethiazide—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00553	0.00577	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Etoposide—peripheral nervous system neoplasm	0.00542	0.00565	CcSEcCtD
Hydroflumethiazide—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00541	0.00565	CcSEcCtD
Hydroflumethiazide—Glycosuria—Doxorubicin—peripheral nervous system neoplasm	0.00531	0.00554	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.00529	0.00552	CcSEcCtD
Hydroflumethiazide—KCNMA1—ganglion—peripheral nervous system neoplasm	0.00508	0.124	CbGeAlD
Hydroflumethiazide—Hyperuricaemia—Epirubicin—peripheral nervous system neoplasm	0.00501	0.00523	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00494	0.00515	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.0049	0.00511	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.0049	0.00511	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.0049	0.0051	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00483	0.00504	CcSEcCtD
Hydroflumethiazide—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00481	0.00501	CcSEcCtD
Hydroflumethiazide—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00477	0.00497	CcSEcCtD
Hydroflumethiazide—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00477	0.00497	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Epirubicin—peripheral nervous system neoplasm	0.00473	0.00494	CcSEcCtD
Hydroflumethiazide—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00471	0.00491	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Doxorubicin—peripheral nervous system neoplasm	0.00464	0.00483	CcSEcCtD
Hydroflumethiazide—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00452	0.00472	CcSEcCtD
Hydroflumethiazide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00448	0.00468	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00438	0.00457	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Doxorubicin—peripheral nervous system neoplasm	0.00438	0.00457	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00436	0.00455	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00435	0.00453	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00435	0.00453	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00433	0.00451	CcSEcCtD
Hydroflumethiazide—Constipation—Topotecan—peripheral nervous system neoplasm	0.00431	0.0045	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00429	0.00447	CcSEcCtD
Hydroflumethiazide—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00428	0.00446	CcSEcCtD
Hydroflumethiazide—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00428	0.00446	CcSEcCtD
Hydroflumethiazide—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00427	0.00445	CcSEcCtD
Hydroflumethiazide—Agitation—Vincristine—peripheral nervous system neoplasm	0.00411	0.00429	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00404	0.00421	CcSEcCtD
Hydroflumethiazide—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00402	0.00419	CcSEcCtD
Hydroflumethiazide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00401	0.00418	CcSEcCtD
Hydroflumethiazide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00401	0.00418	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.004	0.00417	CcSEcCtD
Hydroflumethiazide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00397	0.00414	CcSEcCtD
Hydroflumethiazide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00397	0.00414	CcSEcCtD
Hydroflumethiazide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00392	0.00409	CcSEcCtD
Hydroflumethiazide—CA1—nerve—peripheral nervous system neoplasm	0.00391	0.0955	CbGeAlD
Hydroflumethiazide—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.0039	0.00406	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00384	0.00401	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.0038	0.00397	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.00377	0.00393	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00371	0.00387	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00371	0.00387	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00369	0.00384	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00369	0.00384	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00364	0.00379	CcSEcCtD
Hydroflumethiazide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00362	0.00377	CcSEcCtD
Hydroflumethiazide—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00361	0.00377	CcSEcCtD
Hydroflumethiazide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00359	0.00374	CcSEcCtD
Hydroflumethiazide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00359	0.00374	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00358	0.00373	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00356	0.00371	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00355	0.00371	CcSEcCtD
Hydroflumethiazide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00354	0.00369	CcSEcCtD
Hydroflumethiazide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00354	0.00369	CcSEcCtD
Hydroflumethiazide—Purpura—Epirubicin—peripheral nervous system neoplasm	0.0035	0.00365	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.00349	0.00364	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00349	0.00363	CcSEcCtD
Hydroflumethiazide—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00348	0.00363	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00345	0.0036	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00342	0.00357	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00342	0.00357	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00338	0.00352	CcSEcCtD
Hydroflumethiazide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00333	0.00348	CcSEcCtD
Hydroflumethiazide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00331	0.00345	CcSEcCtD
Hydroflumethiazide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00331	0.00345	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.0033	0.00344	CcSEcCtD
Hydroflumethiazide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00326	0.0034	CcSEcCtD
Hydroflumethiazide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00325	0.00338	CcSEcCtD
Hydroflumethiazide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00324	0.00338	CcSEcCtD
Hydroflumethiazide—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.00324	0.00338	CcSEcCtD
Hydroflumethiazide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00321	0.00334	CcSEcCtD
Hydroflumethiazide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00318	0.00332	CcSEcCtD
Hydroflumethiazide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00318	0.00332	CcSEcCtD
Hydroflumethiazide—Rash—Topotecan—peripheral nervous system neoplasm	0.00318	0.00331	CcSEcCtD
Hydroflumethiazide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00318	0.00331	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00318	0.00331	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00316	0.0033	CcSEcCtD
Hydroflumethiazide—Headache—Topotecan—peripheral nervous system neoplasm	0.00316	0.00329	CcSEcCtD
Hydroflumethiazide—Rash—Tretinoin—peripheral nervous system neoplasm	0.00315	0.00329	CcSEcCtD
Hydroflumethiazide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00315	0.00329	CcSEcCtD
Hydroflumethiazide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00315	0.00329	CcSEcCtD
Hydroflumethiazide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00315	0.00329	CcSEcCtD
Hydroflumethiazide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00314	0.00327	CcSEcCtD
Hydroflumethiazide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00313	0.00327	CcSEcCtD
Hydroflumethiazide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00313	0.00327	CcSEcCtD
Hydroflumethiazide—Constipation—Vincristine—peripheral nervous system neoplasm	0.00312	0.00326	CcSEcCtD
Hydroflumethiazide—Rash—Melphalan—peripheral nervous system neoplasm	0.00311	0.00325	CcSEcCtD
Hydroflumethiazide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00311	0.00324	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00308	0.00321	CcSEcCtD
Hydroflumethiazide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00308	0.00321	CcSEcCtD
Hydroflumethiazide—CA4—nerve—peripheral nervous system neoplasm	0.00305	0.0746	CbGeAlD
Hydroflumethiazide—CA4—ganglion—peripheral nervous system neoplasm	0.00302	0.0737	CbGeAlD
Hydroflumethiazide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00301	0.00314	CcSEcCtD
Hydroflumethiazide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00301	0.00314	CcSEcCtD
Hydroflumethiazide—Nausea—Topotecan—peripheral nervous system neoplasm	0.003	0.00312	CcSEcCtD
Hydroflumethiazide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00297	0.0031	CcSEcCtD
Hydroflumethiazide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00297	0.0031	CcSEcCtD
Hydroflumethiazide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00293	0.00306	CcSEcCtD
Hydroflumethiazide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00293	0.00306	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.0029	0.00302	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00286	0.00298	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00285	0.00297	CcSEcCtD
Hydroflumethiazide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00282	0.00294	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00281	0.00293	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0028	0.00292	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00279	0.00291	CcSEcCtD
Hydroflumethiazide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00272	0.00284	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00269	0.00281	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00266	0.00278	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00265	0.00276	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00263	0.00274	CcSEcCtD
Hydroflumethiazide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00262	0.00273	CcSEcCtD
Hydroflumethiazide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.0026	0.00271	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00259	0.0027	CcSEcCtD
Hydroflumethiazide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00258	0.00269	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00257	0.00268	CcSEcCtD
Hydroflumethiazide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00253	0.00264	CcSEcCtD
Hydroflumethiazide—Constipation—Etoposide—peripheral nervous system neoplasm	0.00253	0.00264	CcSEcCtD
Hydroflumethiazide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00251	0.00261	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.0025	0.00261	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00246	0.00257	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00243	0.00254	CcSEcCtD
Hydroflumethiazide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00243	0.00253	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00243	0.00253	CcSEcCtD
Hydroflumethiazide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00242	0.00252	CcSEcCtD
Hydroflumethiazide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00251	CcSEcCtD
Hydroflumethiazide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00239	0.00249	CcSEcCtD
Hydroflumethiazide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00239	0.00249	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00238	0.00248	CcSEcCtD
Hydroflumethiazide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00237	0.00248	CcSEcCtD
Hydroflumethiazide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00235	0.00245	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00235	0.00245	CcSEcCtD
Hydroflumethiazide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00232	0.00242	CcSEcCtD
Hydroflumethiazide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00232	0.00242	CcSEcCtD
Hydroflumethiazide—Rash—Vincristine—peripheral nervous system neoplasm	0.0023	0.0024	CcSEcCtD
Hydroflumethiazide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.0023	0.0024	CcSEcCtD
Hydroflumethiazide—Headache—Vincristine—peripheral nervous system neoplasm	0.00229	0.00239	CcSEcCtD
Hydroflumethiazide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00225	0.00235	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00225	0.00234	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00221	0.0023	CcSEcCtD
Hydroflumethiazide—KCNMA1—brainstem—peripheral nervous system neoplasm	0.00221	0.054	CbGeAlD
Hydroflumethiazide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00218	0.00227	CcSEcCtD
Hydroflumethiazide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00217	0.00226	CcSEcCtD
Hydroflumethiazide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00212	0.00221	CcSEcCtD
Hydroflumethiazide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00205	0.00214	CcSEcCtD
Hydroflumethiazide—Rash—Cisplatin—peripheral nervous system neoplasm	0.00204	0.00212	CcSEcCtD
Hydroflumethiazide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00203	0.00212	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00202	0.00211	CcSEcCtD
Hydroflumethiazide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00196	0.00204	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00195	0.00204	CcSEcCtD
Hydroflumethiazide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00192	0.002	CcSEcCtD
Hydroflumethiazide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00188	0.00196	CcSEcCtD
Hydroflumethiazide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00187	0.00195	CcSEcCtD
Hydroflumethiazide—Rash—Etoposide—peripheral nervous system neoplasm	0.00187	0.00195	CcSEcCtD
Hydroflumethiazide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00186	0.00194	CcSEcCtD
Hydroflumethiazide—Headache—Etoposide—peripheral nervous system neoplasm	0.00185	0.00193	CcSEcCtD
Hydroflumethiazide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00183	0.0019	CcSEcCtD
Hydroflumethiazide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00182	0.0019	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00181	0.00189	CcSEcCtD
Hydroflumethiazide—Nausea—Etoposide—peripheral nervous system neoplasm	0.00176	0.00183	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.0018	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00176	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.00176	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00162	0.00169	CcSEcCtD
Hydroflumethiazide—CA7—cerebellum—peripheral nervous system neoplasm	0.00161	0.0393	CbGeAlD
Hydroflumethiazide—ATP1A1—trigeminal ganglion—peripheral nervous system neoplasm	0.0016	0.0392	CbGeAlD
Hydroflumethiazide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00158	0.00165	CcSEcCtD
Hydroflumethiazide—ATP1A1—parotid gland—peripheral nervous system neoplasm	0.00151	0.037	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.00157	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00146	0.00153	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00144	0.0015	CcSEcCtD
Hydroflumethiazide—ATP1A1—brainstem—peripheral nervous system neoplasm	0.00142	0.0347	CbGeAlD
Hydroflumethiazide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00148	CcSEcCtD
Hydroflumethiazide—CA9—cerebellum—peripheral nervous system neoplasm	0.00141	0.0345	CbGeAlD
Hydroflumethiazide—CA4—parotid gland—peripheral nervous system neoplasm	0.0014	0.0341	CbGeAlD
Hydroflumethiazide—CA14—cerebellum—peripheral nervous system neoplasm	0.00134	0.0327	CbGeAlD
Hydroflumethiazide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00139	CcSEcCtD
Hydroflumethiazide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00137	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00137	CcSEcCtD
Hydroflumethiazide—CA4—brainstem—peripheral nervous system neoplasm	0.00131	0.032	CbGeAlD
Hydroflumethiazide—CA2—trigeminal ganglion—peripheral nervous system neoplasm	0.00123	0.03	CbGeAlD
Hydroflumethiazide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00127	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00127	CcSEcCtD
Hydroflumethiazide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00124	CcSEcCtD
Hydroflumethiazide—CA2—parotid gland—peripheral nervous system neoplasm	0.00116	0.0283	CbGeAlD
Hydroflumethiazide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00118	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00118	CcSEcCtD
Hydroflumethiazide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00115	CcSEcCtD
Hydroflumethiazide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.0011	0.00114	CcSEcCtD
Hydroflumethiazide—KCNMA1—cerebellum—peripheral nervous system neoplasm	0.00109	0.0266	CbGeAlD
Hydroflumethiazide—CA2—brainstem—peripheral nervous system neoplasm	0.00109	0.0266	CbGeAlD
Hydroflumethiazide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00105	0.0011	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00109	CcSEcCtD
Hydroflumethiazide—Rash—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00109	CcSEcCtD
Hydroflumethiazide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00109	CcSEcCtD
Hydroflumethiazide—Headache—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00108	CcSEcCtD
Hydroflumethiazide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00106	CcSEcCtD
Hydroflumethiazide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000985	0.00103	CcSEcCtD
Hydroflumethiazide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000976	0.00102	CcSEcCtD
Hydroflumethiazide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000968	0.00101	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000967	0.00101	CcSEcCtD
Hydroflumethiazide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000961	0.001	CcSEcCtD
Hydroflumethiazide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000912	0.00095	CcSEcCtD
Hydroflumethiazide—ATP1A1—cerebellum—peripheral nervous system neoplasm	0.000699	0.0171	CbGeAlD
Hydroflumethiazide—CA4—cerebellum—peripheral nervous system neoplasm	0.000646	0.0158	CbGeAlD
Hydroflumethiazide—CA2—cerebellum—peripheral nervous system neoplasm	0.000536	0.0131	CbGeAlD
